OXOID Dryspot Staphytect Plus - HSA Registration DE0015992
Access comprehensive regulatory information for OXOID Dryspot Staphytect Plus in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0015992 and owned by OXOID Limited. The device was registered on July 17, 2014.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
DrySpot™ Staphytect™ Plus kit is a qualitative latex slide agglutination assay for the differentiation of Staphylococcus aureus from other Staphylococcus species isolates grown on agar by the detection of clumping factor, Protein A and certain capsular polysaccharides found in methicillin-resistant Staphylococcus aureus (MRSA). Used in a diagnostic workflow to aid clinicians in treatment options for patients suspected of having staphylococcal infection or colonization. The device is not automated, is for professional use only and is not a companion diagnostic.